Live feed
Filing
SC 13G/A
SC 13G/A0000902219-24-000050·Blueprint Medicines Corp
Schedule 13G ownership disclosure
N/A
Security class unavailable · CUSIP: 09627Y109
Event date: 2023-12-29
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,276,333
- Percent of class
- 7.0300%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902219-24-000050
- Form type
- SC 13G/A
- Filer
- Blueprint Medicines Corp
- CIK
- CIK 1597264
- Filed
- Feb 08, 2024
- Reporting period
- Dec 29, 2023
- Description
- Schedule 13G beneficial ownership